SCHEMBL9711174

SCHEMBL9711174

CC(C)(C)c1ccc(SC(C(=O)O)[N+](=O)[O-])cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 2/20 0.45
HSP90AA1 P07900 1/20 0.45
THRB P10828 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.38
SRD5A2 P31213 1/20 0.38
KIF11 P52732 1/20 0.38
SLC1A2 P43004 1/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
ESRRG P62508 1/20 0.36
MAPK1 P28482 2/20 0.35
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
GLA P06280 1/20 0.35
CASP3 P42574 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11516166 0.75 ALDH1A1 (0.51) ALDH1A1MAPTNPSR1LMNAHSP90AA1
SCHEMBL23368374 0.66 ALDH1A1 (0.52) ALDH1A1MAPTNPSR1LMNAHSP90AA1
SCHEMBL13403334 0.66 TSHR (0.44) ALDH1A1MAPTNPSR1LMNAHSP90AA1
SCHEMBL5026702 0.65 MAPT (0.59) ALDH1A1MAPTNPSR1LMNASMN1; SMN2
SCHEMBL9711221 0.65 ALDH1A1 (0.50) ALDH1A1MAPTLMNASMN1; SMN2NPC1
SCHEMBL11872600 0.65 HPGD (0.42) ALDH1A1MAPTNPSR1LMNAHSP90AA1
SCHEMBL19154876 0.64 TSHR (0.42) ALDH1A1MAPTNPSR1LMNAHSP90AA1
Hydrogen Peroxide SCHEMBL28677809 0.64 LMNA (0.71) ALDH1A1MAPTLMNASMN1; SMN2SRD5A2
SCHEMBL5608985 0.64 GRIA4 (0.41) ALDH1A1LMNASMN1; SMN2KIF11TP53
SCHEMBL11863781 0.64 CTSD (0.43) ALDH1A1MAPTNPSR1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153227-A Treatment of diabetes and galactosemia complications IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-10-06 US disclosed
EP-0304190-B1 (ARYLSULPHONYL)NITROMETHANES, PROCESS FOR THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-08 EP disclosed
EP-0304190-A1 (Arylsulphonyl)nitromethanes, process for their preparation and use in pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-22 EP disclosed